BackAnavex Life Sciences Overview

Anavex Life Sciences Current Cash

Anavex Life Sciences's current cash is $120M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$118.33M
↑ 16.96% YoYΔ $17.16M vs prior year quarter

Peer trimmed avg / median

Loading

Anavex Life Sciences Current Cash History

Loading

Anavex Life Sciences vs. peers: Current Cash Comparison

Loading

Anavex Life Sciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Anavex Life Sciences (AVXL) FAQ

Anavex Life Sciences (AVXL) currently reports a current cash of $120M as of June 2026. That compares with $100M in the prior-year period — up 17.0% year over year. Use the charts on this page to explore Anavex Life Sciences's current cash history and peer comparisons.

Anavex Life Sciences's current cash increased from $100M to $120M — a 17.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anavex Life Sciences reported $120M in current cash as of June 2026. That compares with $100M in the prior-year period — up 17.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anavex Life Sciences, and consider following AVXL for alerts when major investors trade the stock.

Anavex Life Sciences is classified in the Healthcare sector. On current cash, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVXL with unrelated industries.